David Zhang


  • JD, The George Washington University Law School, 2009
  • BA (Psychology), summa cum laude, The George Washington University, 2005; Presidential Academic Scholarship Award 2002-2005


  • Hong Kong, Registered Foreign Lawyer (New York)
  • New York, 2010
  • Chinese (Mandarin)

David Zhang


View the Chinese version.

David Zhang joined Ropes & Gray’s government enforcement practice group in 2012. His practice concentrates on advising clients on internal investigations, due diligence, and compliance programs, particularly with a focus on anti-corruption and anti-bribery matters in China.

David has represented and conducted internal investigations for multinational and U.S.-listed clients across different industries, including pharmaceutical, medical device, internet and technology, hotel and hospitality, venture capital/private equity and aerospace and aviation. David is natively bilingual in English and Mandarin Chinese, and he has extensive cultural knowledge of the China region.

David is currently on assignment in Hong Kong and he is a Registered Foreign Lawyer of the Hong Kong office.


  • Conducted numerous internal investigations related to anti-corruption, off- label promotion and export compliance for Fortune 100 multinational life sciences companies.
  • Conducted an anti-corruption internal investigation for U.S.-listed internet technology company, including advising the client on self-disclosure to U.S. DOJ and SEC.
  • Conducted an anti-corruption internal investigation for U.S.-listed and privately-held companies across different industries, including hotel management, food & beverage, and industrial equipment and technology.
  • Advised multi-national medical device company regarding its government-appointed compliance monitorship.
  • Conducted a number of comprehensive compliance risk assessment and post-acquisition due diligence of multinational life sciences companies’ local subsidiaries and operations.
  • Advised international venture capital and private equity funds on various anti-corruption and trade compliance due diligence for investments in Asia.
  • Conducted anti-corruption training in Mandarin and English for local employees of multinational corporations and portfolio companies of international investment funds.
  • Advised clients on developing and implementing anti-corruption compliance policies and procedures, channel and third-party risk management measures, and internal monitoring and control mechanisms for local operations of multinational corporations.
  • Previously seconded to a Fortune 50 pharmaceutical company to assist with compliance and internal investigation matters.



  • Panelist, “The FCPA Pilot Program and considerations in evaluating voluntary self-disclosure” Ropes & Gray Medical Device Roundtable (May 2017)
  • Panelist, “FCPA Pilot Program: The Value of Self-disclosure” Ropes & Gray Roundtable in conjunction with Chambers, Shanghai (May 2017)